Background/Aims: Minimally invasive treatments have emerged as the frontline therapy for patients with early gastric cancer (EGC). However, some cT1N0 patients with EGC may have lymph node metastasis because of inadequate evaluation. This study aimed to investigate the diagnostic accuracy of sentinel lymph node (SLN) and tried to find out feasible criteria for SLN-guided minimally invasive surgery for EGC. Methods: A solitary metastasis lymph node was taken as SLN, the features of lymph node metastasis were analyzed retrospectively in 255 patients with EGC, and the result was then compared with a SLN biopsy in 23 patients with EGC. Results: Depth of invasion and tumor size were independent risk factors for lymph node metastasis in EGC. The lymph node metastasis rate for mucosal carcinoma with a diameter <4 cm was 2.5%, and it was 13.3% when the diameter was ≥4 cm (p = 0.040). For submucosal carcinoma, it was 25.4% when the tumor diameter was <3 cm and 50.5% when the diameter was ≥3 cm (p = 0.003). The accuracy, sensitivity, and specificity of SLN biopsy in EGC was 100%, respectively. The distribution characteristics of SLN were consistent with those of lymph node metastasis in EGC. Conclusions: SLN-guided minimally invasive surgery could be safely performed in EGC according to feasible criteria.

Keywords:
Esophagus cancer, Stomach cancer, Minimally invasive surgery, Surgical techniques
1.
Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T: Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg 2001;88:444–449.
2.
Kitano S, Bandoh T, Kawano K: Endoscopic surgery in Japan. Minim Invasive Ther Allied Technol 2001;10:215–219.
3.
Japanese Gastric Cancer Association: Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach (in English). April 2004 edition. http://www.jgca.jp/PDFfiles/Guidelines2004_eng.pdf.
4.
Ichikura T, Chochi K, Sugasawa H, Yaguchi Y, Sakamoto N, Takahata R, Kosuda S, Mochizuki H: Individualized surgery for early gastric cancer guided by sentinel node biopsy. Surgery 2006;139:501–507.
5.
Nakahara T, Kitagawa Y, Yakeuchi H, Fujii H, Suzuki T, Mukai M, Kitajima M, Kubo A: Preoperative lymphoscintigraphy for detection of sentinel lymph node in patients with gastric cancer – initial experience. Ann Surg Oncol 2008;15:1447–1453.
6.
Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A: Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 2003;90:178–182.
7.
Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Matsuda J, Kumai K, Ikeda T, Kubo A, Kitajima M: Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol 2001;8:86S–89S.
8.
Ludwig K, Klautke G, Bernhard J, Weiner R: Minimally invasive and local treatment for mucosal early gastric cancer. Surg Endosc 2005;19:1362–1366.
9.
Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma – 2nd English Edition. Gastric Cancer 1998;1:10–24.
10.
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y: Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000;3:219–225.
11.
American Joint Committee on Cancer: AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002, pp 1–101.
12.
Karube T, Ochiai T, Shimada H, Nikaidou T, Hayashi H: Detection of sentinel lymph nodes in gastric cancers based on immunohistochemical analysis of micrometastases. J Surg Oncol 2004;87:32–38.
13.
Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–373.
14.
Kuntz C, Herfarth C: Imaging diagnosis for staging of gastric cancer. Semin Surg Oncol 1999;17:96–102.
15.
Woo SK, Kim S, Kim TU, Lee JW, Kim GH, Choi KU, Jeon TY: Investigation of the association between CT detection of early gastric cancer and ultimate histology. Clin Radiol 2008;63:1236–1244.
16.
Uenosono Y, Natsugoe S, Ehi K, Arigami T, Hokita S, Aikou T: Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg 2005, 92:886–889.
17.
Yanagita S, Natsugoe S, Uenosono Y, Kozono T, Ehi K, Arigami T, Arima H, Ishigami S, Aikou T: Sentinel node micrometastases have high proliferative potential in gastric cancer. J Surg Res 2008;145:238–243.
18.
Isozaki H, Kimura T, Tanaka N: An assessment of the feasibility of sentinel lymph node-guided surgery for gastric cancer. Gastric Cancer 2004;7:149–153.
19.
Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, Arima H, Yanagida S, Ishigami S, Hokita S, Aikou T: Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg 2006;243:341–347.
20.
Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, Chagpar A, Julian T, Saha S, Mamounas E, Giuliano A, Simmons R: Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 2007;194:426–432.
21.
Hughes SJ, Xi L, Raja S, Gooding W, Cole DJ, Gillanders WE, Mikhitarian K, McCarty K, Silver S, Ching J, McMillan W, Luketich JD, Godfrey TE: A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 2006;243:389–398.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.